pH-dependent self-assembling behavior of imidazole-containing polyaspartamide derivatives

Journal of Biomedical Materials Research - Part A

Volumn 90, Issue 2, 2009, Pages 478-486

  Seo, Kwangwon ^a   Kim, Jong Duk ^b   Kim, Dukjoon ^a  

^a Sungkyunkwan University   (South Korea)

^b Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

Author keywords

1 (3 aminopropyl) imidazole; Drug delivery systems; Graft copolymers; pH sensitive polymers; Polymer aggregates

Indexed keywords

1-(3-AMINOPROPYL) IMIDAZOLE; BUFFERING CAPACITIES; DEAGGREGATION; DEGREE OF SUBSTITUTION; DRUG-DELIVERY SYSTEMS; HYDROPHILIC GROUPS; MEAN SIZE; OCTADECYLAMINE; PH SENSITIVE; PH-DEPENDENCE; PH-DEPENDENT; PH-SENSITIVE POLYMERS; POLYASPARTAMIDE; POLYMER AGGREGATES; POLYMER COMPOSITION; SELF-ASSEMBLING; TUMOR TARGETING;

AGGREGATES; COPOLYMERIZATION; DIELECTRIC RELAXATION; ETHYLENE GLYCOL; GRAFT COPOLYMERS; GRAFTING (CHEMICAL); MOTION PICTURE EXPERTS GROUP STANDARDS; POLYMER SOLUTIONS; POTENTIOMETRIC SENSORS;

POLYMERS;

1 (3 AMINOPYL)IMIDAZOLE; AMIDE; IMIDAZOLE; MACROGOL; O (2 AMINOETHYL) O' METHYLPOLYETHYLENE GLYCOL; OCTADECYLAMINE; POLYASPARATAMIDE DERIVATIVE; POLYASPARTIC ACID; POLYMER; UNCLASSIFIED DRUG;

ARTICLE; CONJUGATION; PH; PROTON TRANSPORT; SOLUTION AND SOLUBILITY; ULTRAVIOLET RADIATION;

AMINES; ASPARTIC ACID; BUFFERS; DIMETHYLFORMAMIDE; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HYDROGEN-ION CONCENTRATION; IMIDAZOLES; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, CHEMICAL; PARTICLE SIZE; PEPTIDES; POLYMERS; PROTEINS; SPECTROMETRY, FLUORESCENCE; ULTRAVIOLET RAYS;

EID: 67650503192     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.32086     Document Type: Article

References (29)

1. Allen C, Maysinger D, Eisenberg A. Nano-engineering block copolymer aggregates for drug delivery. Colloids Surf B 1999; 16:3-27.
2. Torchilin VP. Structure and design of polymeric surfactantbased drug delivery systems. J Control Release 2001;73:137-172.
3. Panyam J, Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev 2003;55:329-347.
4. Cavallaro G, Licciardi M, Giammona G, Caliceti P, Semenzato A, Salmaso S. Poly(hydroxyehylaspartamide) derivatives as colloidal drug carrier systems. J Control Release 2003;89:285-295.
5. Kang HS, Yang SR, Kim JD, Han SH, Chang IS. Effects of grafted alkyl groups on aggregation behavior of amphiphilic poly(aspartic acid). Langmuir 2001;17:7501-7506.
6. Jeong JH, Kang HS, Yang SR, Kim JD. Polymer micelle-like aggregates of novel amphiphilic biodegradable poly(asparagines) grafted with poly(caprolactone). Polymer 2003;44:583-591.
7. Jeong JH, Kang HS, Yang SR, Park K, Kim JD. Biodegradable poly(asparagines) grafted with poly(caprolactone) and the effect of substitution on self-aggregation. Colloids Surf A 2005; 264:187-194.
8. Suwa M, Hashidzume A, Morishima Y, Nakato T, Tomida M. Self-association behavior of hydrophobically modified poly (aspartic acid) in water studied by fluorescence and dynamic light scattering techniques. Macromolecules 2000;33:7884-7892.
9. Yokoyama M, Miyauchi M, Yamada N, Okano T. Polymer micelles as novel drug carrier: Adriamycin-conjugated poly (ethylene glycol)-poly(aspartic acid) block copolymer. J Control Release 1990;11:269-278.
10. Stubbs M, McSheehy PM, Griffiths JR, Bashford CL. Causes and consequences of tumour acidity and implications for treatment. Mol Med Today 2000;6:15-19.
11. Maeda A, Wu J, Sawa T, Matsumura Y, Hori K. Tumor vascular permeability and the EPR effect in macromoleculear therapeutics: A review. J Control Release 2000;65:271-284.
12. Jones MC, Leroux JC. Polymeric micelles-a new generation of colloidal drug carrier. Eur J Pharm Biopharm 1999;48:101-111.
13. Lloyd JB. The lysosome/endosome membrane: A barrier to polymer-based drug delivery. Macromol Symp 2001;172:29-34.
14. Sheff D. Endosomes as route for drug delivery in the real world. Adv Drug Deliv Rev 2004;56:927-930.
15. Drummond DC, Zignani M, Leroux JC. Current status of pHsensitive liposome in drug delivery. Prog Lipid Res 2000;39: 409-460.
16. Patchornik A, Berger A, Katchalski E. Poly-L-histidine. J Am Chem Soc 1957;79:5227-5230.
17. Midoux P, Monsigny M. Efficient gene transfer by histidylated polylysine/pDNA complexes. Bioconjugate Chem 1999;10: 406-411.
18. Wang CY, Huang L. Polyhistidine mediates an acid-dependent fusion of negatively charged liposomes. Biochemistry 1984;23:4409-4416.
19. Pichon C, Concalves C, Midoux P. Histidine-rich peptides and polymers for nucleic acids delivery. Adv Drug Deliv Rev 2001;53:75-94.
20. Pack DW, Putnam D, Langer R. Design of imidazole-containing endosomolytic biopolymers for gene delivery. Biotechnol Bioeng 2000;67:217-223.
21. Lee ES, Shin HJ, Na K, Bae YH. Poly(L-histidine)-PEG block copolymer miocelles and pH-induced destabilization. J Control Release 2003;90:363-374.
22. Kim GM, Bae YH, Jo WH. pH-induced micelle formation of poly(histidine-co-phenylalanine)-block-poly(ethylene glycol) in aqueous media. Macromol Biosci 2005;5:1118-1124.
23. Lee ES, Na K, Bae YH. Super pH-sensitive multifunctional polymeric micelle. Nano Lett 2005;5:325-329.
24. Ihm JE, Han KO, Han IK, Ahn KD, Han DK, Cho CS. High transfection efficiency of poly(4-vinylimidazole) as a new gene carrier. Bioconjugate Chem 2003;14:707-708.
25. Ihm JE, Han KO, Hwang CS, Kang JH, Ahn KD, Han IK, Han DK, Hubbell JA, Cho CS. Poly(4-vinylimidazole) as non viral gene carrier in vitro and in vivo transfection. Acta Biomater 2005;1:165-172.
26. Yang S, Lee H, Kim J. Histidine-conjugated poly(amino acid) derivatives for the novel endosomolytic delivery carrier of doxorubicin. J Control Release 2006;114:60-68.
27. Seo K, Kim D. Phase transition behavior of novel pH-sensitive polyaspartamide derivatives grafted with 1-(3-aminopropyl) imidazole. Macromol Biosci 2006;6:758-766.
28. Tomida M, Nakato T. Convenient synthesis of high molecular weight poly(succinimide) by acid-catalysed polycondensation of L-aspartic acid. Polymer 1997;38:4733-4736.
29. Neri P, Antoni G, Benvenuti F, Colola F, Gazzei G. Synthesis of a,b-poly[(2-hydroxyethyl)-DL-aspartamide], a new plasma expander. J Med Chem 1972;16:893-897.